Abstract
5-Hydroxytryptamine (serotonin, 5-HT), essentially known as a neurotransmitter and vasoactive agent, also functions as a mitogen in various cell types through several different second messenger systems. Stimulation of cloned human 5-HT1D receptor sites by sumatriptan in stably transfected rat C6-glial/5-HT1D cells promotes cell growth (Pauwels et al. (1996) Naunyn-Schmiedeberg's Arch Pharmacol 353:144–156). In the present study, the pharmacology of this growth response was investigated using a broad series of 5-HT receptor ligands. The data were compared with the responses obtained by measuring inhibition of forskolin-stimulated cAMP formation. 5-HT (EC50: 25 nM) promoted cell growth of C6-glial/5-HT1D cells, and this in contrast to the absence of any measurable effect in pcDNA3-plasmid transfected and non-transfected C6-glial cells. The 5-HT effect could be mimicked by the following compounds (EC50 in nM): zolmitriptan (0.41), 2′-methyl-4′-(5-methyl[1,2,4] oxadiazol-3-yl)biphenyl-4-carboxylic acid [4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]amide (GR 127,935; 0.86), naratriptan (0.92), metergoline (1.9), sumatriptan (2.9), (N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-y)]ethylamine (MK-462; 3.0), and R(+)-8-hydroxy-2-(di-n-propylamino)tetralin (R(+)-8-OH-DPAT; 30.7). These EC50-values correspond to the compounds binding affinities at the human 5-HT1D receptor site and, with the exception of GR 127,935 and metergoline, also to the EC50-values found by measuring over 5 min inhibition of forskolin (100 μM)-stimulated cAMP formation. Prolonged exposure of GR 127,935 (3 h) and metergoline (30 min) to cells yielded EC50 values in the cAMP assay more close to those measured in the mitogenic response. The growth response to sumatriptan, 5-HT, GR 127,935 and metergoline was blocked by the apparently silent antagonists methiothepin, ritanserin and ketanserin with potencies similar to blockade of inhibition of stimulated CAMP formation. The 8-OH-DPAT effect also is likely mediated by 5-HT1D receptors; stereoselectivity was found with its enantiomers at this receptor site and the effect was blocked by ketanserin (1 μM) but not by spiperone (1 μM). Micromolar concentrations of the 5-HT1B receptor agonist 3-(1,2,5,6-tetrahydro)-4-pyridil-5-pyrrolo[3, 2-b]pyril-5-one (CP 93,129) and of the 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) induced cell growth with a potency that accorded with the affinity of these compounds for the human 5-HT1D receptor site. These effects were sensitive to ketanserin (1 μM) antagonism, but not to blockade by β-adrenergic blockers and the 5-HT2 receptor antagonist 2-anilino-N-[2-(3-chlorophenoxy)-propyl] acetamidine hydroiodide (BW 501-C-67). The findings suggest that 5-HT1A, 5-HT1B and 5-HT2 receptors are not implicated in 5-HT-stimulated C6-glial/5-HT1D cell growth. In conclusion, human 5-HT1D receptors are involved in the growth of C6-glial/5-HT1D cells. This cellular response is highly sensitive to the intrinsic activity of compounds at 5-HT1D receptors.
Similar content being viewed by others
References
Abdel-Baset H, Bozovic V, Szyf M, Albert P R (1992) Conditional transformation mediated via a pertussis toxin-sensitive receptor signalling pathway. Mol Endocrinol 6:730–740
Ananth US, Leli U, Hauser G (1987) Stimulation of phosphoinositide hydrolysis by serotonin in C6 glioma cells. J Neurochem 48:253–261
Clitherow JW, Scopes DIC, Skingle M, Jordan CC, Feniuk W, Campbell IB, Carter MC, Collington EW, Connor HE, Higgins GA, Beattie D, Kelly HA, Mitchell WE, Oxford AW, Wadsworth AH, Tyers MB (1994) Evolution of a novel series of [(N,N-Dimethylamino)propyl]-and piperazinylbenzanilides as the first selective 5-HT1D antagonists. J Med Chem 37:2253–2257
Cornfield LJ, Lambert G, Arvidsson LE, Mellin C, Vallgarda J, Hacksell U, Nelson DL (1991) Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogues at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase. Mol Pharmacol 39:780–787
Glennon RA, Westkaemper RB (1993) 5-HT1D receptors: A serotonin receptor population for the 1990s. Drug News Perspectives 6:390–405
Gozlan H, Thibault S, Laporte A-M, Lima L, Hamon M (1995) The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HTA receptors in rat brain membranes. Eur J Pharmacol Mol Pharmacol Sect 288:173–186
Hamblin MW, Metcalf MA (1991) Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol Pharmacol 40:143–148
Hamel E, Fan E, Linville D, Ting V, Villemure JG, Chia LS (1993) Expression of mRNA for the serotonin 5-hydroxytryptamine1Dβ receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 44:242–246
Hatcher JP, Slade PD, Roberts C, Hagan JJ (1995) 5-HT1D receptors mediate SKF 99101H-induced hypothermia in the guinea pig. J Psychopharmacol 9:234–241
Julius D, Livelli TJ, Jessell TM, Axel R (1989) Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. Science 244:1057–1062
Kahan C, Julius D, Pouyssègur J, Seuwen K (1992) Effects of 5-HT1C-receptor expression on cell proliferation control in hamster fibroblasts: serotonin fails to induce a transformed phenotype. Exp Cell Res 200:523–527
Kaumann AJ, Frenken M, Posival H, Brown AM (1994) Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. Circulation 90:1141–1153
Pauwels PJ, Van Gompel P, Leysen J E (1990) Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. Life Sci 47:2009–2019
Pauwels PJ, Palmier C (1994) Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in Chinese hamster lung fibroblasts and opossum renal epithelial cells. J Pharmacol Exp Ther 270:938–945
Pauwels PJ, Colpaert FC (1995) The 5-HT1D receptor antagonist GR 127,935 is an agonist at cloned human 5-HT1Dα receptor sites. Neuropharmacology 34:235–237
Pauwels PJ, Colpaert FC (1996) Stereoselectivity of 8-OH-DPAT enantiomers at cloned human 5-HT1D receptor sites. Eur J Pharmacol 300:137–139
Pauwels PJ, Palmier C, Wurch T, Colpaert FC (1996a) Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors. Naunyn-Schmiedeberg's Arch Pharmacol 353:144–156
Pauwels PJ, Wurch T, Amoureux MC, Palmier C, Colpaert FC (1996b) Stimulation of cloned human 5-HT1Dβ receptor sites in stably transfected C6-glial cells promotes cell growth. J Neurochem 66:65–73
Peroutka SJ (1994) Pharmacological differentiation of human 5-HT1B and 5-HT1D receptors. Biol Signals 3:217–222
Raymond JR, Fargin A, Middleton JP, Graff JM, Haupt DM, Caron MG, Lefkowitz RJ, Dennis VW (1989) The human 5-HT1A receptor expressed in HeLa cells stimulates sodium dependent phosphate uptake via protein kinase C. J Biol Chem 264:21943–21950
Razzaque Z, Longmore J, Hill RG (1995) Differences in the effects of ketanserin and GR 127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein. Eur J Pharmacol 283:199–266
Rebeck GW, Maynard KI, Human BT, Moskowitz MA (1994) Selective 5-HT1Dα serotonin receptor gene expression in trigeminal ganglia: implication for antimigraine drug development. Proc Natl Acad Sci USA 91:3666–3669
Routledge C, Gurling J, Wright IK, Dourish CT (1993) Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. Eur J Pharmacol 239:195–202
Seuwen K, Pouyssègur J (1990) Serotonin as a growth factor. Biochem Pharmacol 39:985–990
Skingle M, Higgins GA, Feniuk W (1994) Stimulation of central 5-HT1D receptors causes hypothermia in the guinea-pig. J Psychopharmacol 8:14–21
Starkey SJ, Skingle M (1994) 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphè nucleus. Neuropharmacology 33:393–402
Van Obberghen Schilling E, Vouret Craviara V, Haslam RJ, Chambard JC, Pouyssegur J (1991) Cloning, functional expression and role in cell growth regulation of a hamster 5-HT2 receptor subtype. Mol Endocrinol 5:881–889
Varrault A, Bockaert J, Waeber C (1992) Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis. Mol Biol Cell 3:961–969
Weinshank RL, Zgombick JM, Macchi MJ, Branchek TA, Hartig PR (1992) Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc Natl Acad Sci USA 89:3630–3634
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pauwels, P.J., Wurch, T., Palmier, C. et al. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors. Naunyn-Schmiedeberg's Arch Pharmacol 354, 136–144 (1996). https://doi.org/10.1007/BF00178713
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00178713